Relevium Engages PipeDreemz as Lead ACMPR Consultant for Biocannabix
Relevium Technologies Inc. (TSX.V:RLV (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has engaged PipeDreemz as lead consultant (the “Consultant”) for the Biocannabix Health Corp (“BHC”) ACMPR applications to Health Canada to obtain the necessary licenses. Biocannabix will focus on organic products and on the development of specialty genetic strains targeting primarily cannabidiol (CBD) and cannabigerol (CBG) for use in medical applications as well as consumer packaged goods.
- Industry veteran Georges Routhier and PipeDreemz have been providing advisory services to a number of successful Licensees
- Instrumental in designing the H2 Biopharma facility in Lachute, Qc., acquired by Aurora Cannabis
- The PipeDreemz team holds advanced degrees in science, engineering, business, agriculture, horticulture and plant sciences
- As at January 1, 2018 PipeDreemz had 23 highly advanced facilities under construction across Canada
- ACMPR license application submission forecasted for Summer 2018
Aurelio Useche, CEO of Relevium stated: “Since the creation of Biocannabix Health Corp, a wholly-owned subsidiary of Relevium, we have interviewed a multitude of cannabis consultants, key industry suppliers and advisors with a focus on the Quebec market.” Mr. Useche continued: “We are extremely pleased to partner with George Routhier and the team at PipeDreemz who were highly recommended by industry insiders. George is a veteran in the industry, has a proven track record and shared values with Relevium in terms of the evolution of the cannabis business both in Canada and around the world.”
The Company will begin working immediately with the PipeDreemz and its advisors in the evaluation of selected locations in and around Montreal, Quebec, where the company will host its operations. All facets of the operations, from HVAC to security, genetics and micropropagation, to distribution and branding will be taken into consideration in order to ensure aligned strategic fit and the best possible long-term ROI for the company and its shareholders.
The Company anticipates that the application will be deposited to Health Canada before July 31, 2018.
More about PipeDreemz
The founder and CEO of PipeDreemz, George Routhier has over 15 years of experience in Medical Marijuana research and 8 years of experience as a designated grower under MMAR. PipeDreemz is one of the most senior consultants in the Canadian cannabis landscape and has helped clients obtain over 16 Licensed Producers since inception. PipeDreemz offers a turnkey, start to finish service and has never had a Licensed Producer application fail at Health Canada.
PipeDreemz cemented its position as an expert in the cannabis field following the sale of a PipeDreemz designed state-of-the-art, 49,000 square foot cannabis production facility to Aurora Cannabis Inc. H2 Biopharma retained PipeDreemz for start to finish services including design and oversight on construction of the facility, located in Lachute, Quebec. Aurora Cannabis Inc. acquired the PipeDreemz designed facility from H2 Biopharma in November 2017.
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Fandomfare Gaming Entertainment Video Games | Game Reviews | Game Streaming |Linux Distribution | more than 20-year online gaming and following the gaming industry\
Latest posts by JADIRI GAMER (see all)
- Push to electric vans and trucks will be led by Amazon and other ‘megafleets’carbon neutral - February 20, 2019
- OpenSUSE Leap 15.1 entering Beta phase - February 20, 2019
- Magic the Gathering Arena Become the Next Magic Champion - February 20, 2019